In contrast, STZ‐treated GLO1 transgenic mice are protected from renal dicarbonyl and oxidative stress and from diabetes‐induced kidney pathology, despite hyperglycemia (Giacco et al. 2014). This evidence concerns the gene GLO1 and Hyperglycemia.